Adjuvant methotrexate in CIDP

Peter James Dyck

doi:10.1016/S1474-4422(08)70300-4

Adjuvant methotrexate in CIDP

Neurology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	128-129
Number of pages	2
Journal	The Lancet Neurology
Volume	8
Issue number	2
DOIs	https://doi.org/10.1016/S1474-4422(08)70300-4
State	Published - Feb 2009

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/S1474-4422(08)70300-4

Cite this

@article{333aff7f331d409a935dfde0ce985daa,

title = "Adjuvant methotrexate in CIDP",

author = "Dyck, {Peter James}",

note = "Funding Information: My work is supported in part by an NIH grant (NS 36797) and Mayo Foundation Funds. I have no conflict of interest.",

year = "2009",

month = feb,

doi = "10.1016/S1474-4422(08)70300-4",

language = "English (US)",

volume = "8",

pages = "128--129",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "2",

}

TY - JOUR

T1 - Adjuvant methotrexate in CIDP

AU - Dyck, Peter James

N1 - Funding Information: My work is supported in part by an NIH grant (NS 36797) and Mayo Foundation Funds. I have no conflict of interest.

PY - 2009/2

Y1 - 2009/2

UR - http://www.scopus.com/inward/record.url?scp=58249137414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249137414&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(08)70300-4

DO - 10.1016/S1474-4422(08)70300-4

M3 - Letter

C2 - 19136302

AN - SCOPUS:58249137414

SN - 1474-4422

VL - 8

SP - 128

EP - 129

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 2

ER -

Adjuvant methotrexate in CIDP

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this